Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in exporting chemical products such as potassium iodide, sodium iodide, potassium lodate, calcium iodate, sodium iodate, povidone iodine etc.
Eskay Iodine Private Limited, is an unlisted private company incorporated on 13 September, 2011. It is classified as a private limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 4.00 cr and the total paid-up capital is INR 4.00 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 3
Total Amount : 357.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Bipin Nemchand Shah | 00083244 | 13 years |
Director | Ketan Lalit Shah
Shareholder
|
00083326 | 13 years |
Director | Samir Jayantilal Shah
Shareholder
|
00157396 | 13 years |
Director | Sunil Gulabchand Sharda | 00592625 | 4 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
CHAITANYA LIFE SCIENCE PRIVATE LIMITED |
Active
|
1.5 Cr | 4 | Gujarat |
ITAL PHARCHEM PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
ANUH PHARMA LIMITED |
Active
|
25.1 Cr | 3 | Maharashtra |
MALABAR HILL CLUB LIMITED |
Active
|
0.0 | 1 | Maharashtra |
L P SHAH HOLDINGS AND TRADES PVT LTD |
Converted to LLP and Dissolved
|
1.2 L | 1 | Maharashtra |
L P SHAH HOLDINGS AND TRADES LLP |
Active
|
1.2 L | 1 | Maharashtra |
JAPOSHA TRADING PRIVATE LIMITED |
Converted to LLP
|
1.2 L | 1 | Maharashtra |
PRAGATI PHARMA PRIVATE LIMITED |
Converted to LLP
|
12.0 L | 1 | Maharashtra |
ASHOK GNXT PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
S KANT INDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
SKITES RETAIL PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
JAPOSHA TRADING LLP |
Active
|
1.2 L | 1 | Maharashtra |
SHROFF PHARMA LLP |
Active
|
1.0 L | 1 | Maharashtra |
SEVANTILAL KANTILAL PRIVATE LIMITED |
Active
|
12.0 L | 1 | Maharashtra |
SKITES PHARMA PRIVATE LIMITED |
Active
|
5.9 Cr | 1 | Maharashtra |
S KANT HEALTHCARE LIMITED |
Active
|
98.0 L | 1 | Maharashtra |
ZIRCONIUM CHEMICALS PRIVATE LIMITED |
Active
|
48.0 L | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
CHAITANYA LIFE SCIENCE PRIVATE LIMITED | Gujarat | 2010 | ₹ 1.5 Cr |
The incorporation date of ESKAY IODINE PRIVATE LIMITED is 13 September, 2011
The authorized share capital of ESKAY IODINE PRIVATE LIMITED is INR ₹ 4.0 Cr.
The paid-up capital of ESKAY IODINE PRIVATE LIMITED is INR ₹ 4.0 Cr.
The registered address of ESKAY IODINE PRIVATE LIMITED is A-3, Shivsagar Estate, North Wing Dr. Annie Besant Road, Worli Mumbai Maharashtra - 400018
The CIN number of ESKAY IODINE PRIVATE LIMITED is U24100MH2011PTC221911.